A detailed history of Tci Wealth Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tci Wealth Advisors, Inc. holds 5,444 shares of BMY stock, worth $314,009. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,444
Previous 6,726 19.06%
Holding current value
$314,009
Previous $279,000 0.72%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$39.66 - $51.75 $50,844 - $66,343
-1,282 Reduced 19.06%
5,444 $281,000
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $6,279 - $8,266
-156 Reduced 2.27%
6,726 $279,000
Q1 2024

May 07, 2024

BUY
$47.98 - $54.4 $19,287 - $21,868
402 Added 6.2%
6,882 $373,000
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $6,932 - $8,272
-143 Reduced 2.16%
6,480 $332,000
Q3 2023

Oct 31, 2023

SELL
$57.89 - $64.73 $15,456 - $17,282
-267 Reduced 3.88%
6,623 $384,000
Q2 2023

Aug 04, 2023

SELL
$63.71 - $70.74 $58,613 - $65,080
-920 Reduced 11.78%
6,890 $440,000
Q1 2023

May 03, 2023

SELL
$65.71 - $74.53 $12,484 - $14,160
-190 Reduced 2.38%
7,810 $541,000
Q4 2022

Feb 06, 2023

BUY
$68.48 - $81.09 $48,689 - $57,654
711 Added 9.75%
8,000 $575,000
Q3 2022

Nov 08, 2022

BUY
$0.13 - $76.84 $75 - $44,874
584 Added 8.71%
7,289 $518,000
Q2 2022

Jul 19, 2022

BUY
$72.62 - $79.98 $12,853 - $14,156
177 Added 2.71%
6,705 $516,000
Q1 2022

Apr 29, 2022

BUY
$61.48 - $73.72 $7,193 - $8,625
117 Added 1.82%
6,528 $477,000
Q4 2021

Jan 24, 2022

SELL
$53.63 - $62.52 $37,433 - $43,638
-698 Reduced 9.82%
6,411 $400,000
Q3 2021

Oct 29, 2021

SELL
$59.17 - $69.31 $88,577 - $103,757
-1,497 Reduced 17.39%
7,109 $421,000
Q2 2021

Aug 02, 2021

BUY
$61.91 - $67.42 $5,262 - $5,730
85 Added 1.0%
8,606 $575,000
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $17,920 - $20,155
302 Added 3.67%
8,521 $538,000
Q4 2020

Jan 21, 2021

SELL
$57.74 - $65.43 $716,957 - $812,444
-12,417 Reduced 60.17%
8,219 $510,000
Q3 2020

Oct 20, 2020

BUY
$57.43 - $63.64 $57 - $63
1 Added 0.0%
20,636 $1.24 Million
Q2 2020

Jul 20, 2020

BUY
$54.82 - $64.09 $657 - $769
12 Added 0.06%
20,635 $1.21 Million
Q1 2020

Apr 14, 2020

SELL
$46.4 - $67.43 $79,112 - $114,968
-1,705 Reduced 7.64%
20,623 $1.15 Million
Q4 2019

Jan 27, 2020

BUY
$49.21 - $64.19 $61,807 - $80,622
1,256 Added 5.96%
22,328 $1.43 Million
Q2 2019

Jul 23, 2019

SELL
$44.62 - $49.34 $274,680 - $303,737
-6,156 Reduced 22.61%
21,072 $956,000
Q1 2019

Apr 11, 2019

SELL
$45.12 - $53.8 $1,037 - $1,237
-23 Reduced 0.08%
27,228 $1.3 Million
Q4 2018

Jan 17, 2019

SELL
$48.76 - $63.23 $150,327 - $194,938
-3,083 Reduced 10.16%
27,251 $1.42 Million
Q3 2018

Nov 02, 2018

SELL
$55.19 - $62.25 $3,090 - $3,486
-56 Reduced 0.18%
30,334 $1.88 Million
Q2 2018

Jul 27, 2018

SELL
$50.53 - $62.98 $102,121 - $127,282
-2,021 Reduced 6.24%
30,390 $1.68 Million
Q1 2018

Apr 30, 2018

SELL
$59.92 - $68.98 $659 - $758
-11 Reduced 0.03%
32,411 $2.05 Million
Q4 2017

Feb 01, 2018

SELL
$59.94 - $65.35 $222,976 - $243,101
-3,720 Reduced 10.29%
32,422 $1.99 Million
Q3 2017

Oct 24, 2017

BUY
$55.23 - $63.74 $37,445 - $43,215
678 Added 1.91%
36,142 $2.3 Million
Q2 2017

Aug 10, 2017

BUY
N/A
35,464
35,464 $1.98 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.